Status:
COMPLETED
T2D Pilot Study for Patients With Uncontrolled Type 2 Diabetes
Lead Sponsor:
Duke University
Conditions:
Diabetes Mellitus
Health Behavior
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of the study is to evaluate implementation and determine the effectiveness of a telehealth personal health planning program for individuals with uncontrolled Type 2 Diabetes Mell...
Eligibility Criteria
Inclusion
- Type 2 Diabetes diagnosis
- 18 and over
- 2 A1C results in last 18 months
- A1C of 8-12
- Access to a electronic device with internet
- Duke Patient
Exclusion
- Type 1 Diabetes
- Pregnant
- Blind
- Deaf
- Cognitive Impairment
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06988540
Start Date
September 1 2022
End Date
February 28 2024
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Health System
Durham, North Carolina, United States, 27710